Study of Naltrexone for Methamphetamine Addiction

Plain-language summary

This study evaluates the drug Naltrexone in people with methamphetamine addiction. It enrolled participants aged 18-50 who agreed to the study conditions. The study was conducted in Phase 2 and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Phase 2

Status

Completed

Sponsor

California Pacific Medical Center Research Institute

Intervention

Naltrexone

Start date

9/1/2009

Estimated completion

9/1/2012

Countries

United States

Related genes

Locations

• San Francisco, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Age between 18 and 50 years
* Patient is agreeable to conditions of study and signs consent form